Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;178(6):509-521.
doi: 10.1176/appi.ajp.2020.20030340. Epub 2021 Jan 5.

Neuroimaging Biomarkers in Schizophrenia

Nina V Kraguljac  1 , William M McDonald  1 , Alik S Widge  1 , Carolyn I Rodriguez  1 , Mauricio Tohen  1 , Charles B Nemeroff  1
Affiliations
Review

Neuroimaging Biomarkers in Schizophrenia

Nina V Kraguljac et al. Am J Psychiatry. 2021 Jun.

Abstract

Schizophrenia is a complex neuropsychiatric syndrome with a heterogeneous genetic, neurobiological, and phenotypic profile. Currently, no objective biological measures-that is, biomarkers-are available to inform diagnostic or treatment decisions. Neuroimaging is well positioned for biomarker development in schizophrenia, as it may capture phenotypic variations in molecular and cellular disease targets, or in brain circuits. These mechanistically based biomarkers may represent a direct measure of the pathophysiological underpinnings of the disease process and thus could serve as true intermediate or surrogate endpoints. Effective biomarkers could validate new treatment targets or pathways, predict response, aid in selection of patients for therapy, determine treatment regimens, and provide a rationale for personalized treatments. In this review, the authors discuss a range of mechanistically plausible neuroimaging biomarker candidates, including dopamine hyperactivity, N-methyl-d-aspartate receptor hypofunction, hippocampal hyperactivity, immune dysregulation, dysconnectivity, and cortical gray matter volume loss. They then focus on the putative neuroimaging biomarkers for disease risk, diagnosis, target engagement, and treatment response in schizophrenia. Finally, they highlight areas of unmet need and discuss strategies to advance biomarker development.

Keywords: Biomarker; Neuroimaging; Schizophrenia Spectrum and Other Psychotic Disorders; Work Group on Biomarkers and Novel Treatments of the APA Council of Research.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
A brief introduction to relevant terms in neuroimaging.
Figure 2:
Figure 2:. Mechanistically plausible neuroimaging biomarker development targets.
Based on discovery oriented research a number of mechanistically plausible neuroimaging biomarker development targets have been identified. Diagnostic biomarkers aid in the detection of the presence of a disease state. Target engagement biomarkers confirm therapeutic properties of drugs and can be used for determination of appropriate dosing. Treatment response predication biomarkers guide the appropriate choice of treatment. Therapeutic monitoring biomarkers monitor the response to a specific treatment or monitor relapse of a disorder.
Figure 3:
Figure 3:
Next generation of neuroimaging biomarker studies in schizophrenia.
See this image and copyright information in PMC

References

    1. Group F-NBW: in BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD)2016.
    1. Abi-Dargham A, Horga G. The search for imaging biomarkers in psychiatric disorders. Nat Med. 2016;22:1248–1255. - PubMed
    1. Marquez F, Yassa MA. Neuroimaging Biomarkers for Alzheimer’s Disease. Mol Neurodegener. 2019;14:21. - PMC - PubMed
    1. Kraemer HC, Schultz SK, Arndt S. Biomarkers in psychiatry: methodological issues. Am J Geriatr Psychiatry. 2002;10:653–659. - PubMed
    1. Botteron K, Carter CS, Castellanos FX, Dickstein DP, Drevets W, Kim KL, Pescosolido MF, Rauch S, Seymour KE, Sheline Y, Zubieta J-K: Consensus report of the APA work group on neuroimaging markers of psychiatric disorders. Edited by Association AP. Arlington, VA2012.

Publication types

MeSH terms

LinkOut - more resources